Idiotypic protein-pulsed dendritic cell vaccination in multiple myeloma

International Journal of Cancer

Volumn 83, Issue 2, 1999, Pages 215-222

  Lim, Seah H ^a,b   Bailey Wood, Roy ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE;

ACTIVE IMMUNIZATION; ADULT; AGED; ANTIBODY RESPONSE; ANTIGEN PRESENTATION; ANTINEOPLASTIC ACTIVITY; ARTICLE; B LYMPHOCYTE ACTIVATION; CANCER PREVENTION; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNOGENICITY; INTERFERON PRODUCTION; MALE; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROTEIN TARGETING; T LYMPHOCYTE ACTIVATION;

AGED; AGED, 80 AND OVER; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, NEOPLASM; CANCER VACCINES; DENDRITIC CELLS; FEMALE; HEMOCYANIN; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN IDIOTYPES; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MULTIPLE MYELOMA; T-LYMPHOCYTES, CYTOTOXIC; TIME FACTORS;

EID: 0032834303     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19991008)83:2<215::AID-IJC12>3.0.CO;2-Q     Document Type: Article

References (21)

1. CAMPBELL, M.J., ESSERMAN, L., BYARS, N.E., ALLISON, A.C. and LEVY, R., Idiotype vaccination against murine B cell lymphoma. Humoral and cellular requirements for the full expression of anti-tumor immunity. J. Immunol., 145, 1029-1036 (1990).
2. CAMPBELL, M.J., ESSERMAN, L. and LEVY, R., Immunotherapy of established murine B cell lymphoma: combination of idiotype immunisation and cyclophosphamide. J. Immunol., 141, 3227-3233 (1988).
3. CAUX, C., DUZETTER-DAMBUYANT, C., SCHMITT, D. and BANCHERAEAU, J., GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature (Lond.), 360, 258-260 (1992).
4. COLEMAN, S., THROP, D., FISHER, J., BAILEY-WOOD, R. and LIM, S.H., Cytokine enhancement of immunogenicity in chronic myeloid leukaemia. Leukemia, 11, 2055-2059 (1997).
5. EGNER, W. and HART, D.N.J., The phenotype of freshly isolated and cultured human bone marrow allostimulatory cells: possible heterogeneity in bone marrow dendritic cell populations. Immunology, 85, 611-620 (1995).
6. FLAMAND, V., SORNASSE, T., THIELEMANS, K., DEMANET, G., BAKKUS, M., BAZIN, H., TIELEMANS, F., LEO, O., URBAIN, J. and MUSER, M., Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo. Europ. J. Immunol., 24, 605-610 (1994).
7. GEORGE, A.J., FOLKARD, S.G., HAMBLIN, T.J. and STEVENSON, F.K., Idiotypic vaccination as a treatment for a B cell lymphoma. J. Immunol., 141, 2168-2174 (1988).
8. HATHCOCK, K.S., LASZLO, G., PUCILLO, C., LINSLEY, P. and HODES, R.J., Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J. exp. Med., 180, 631-640 (1994).
9. HSU, F.J., BENIKE, C., FAGNONI, F., LILES, T.M., CZERWINSKI, D., TAIDI, B., ENGELMAN, E.G. and LEVY, R., Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nature (Med.), 2, 52-58 (1996).
10. KWAK, L.W., CAMPBELL, M.J., CZERWINSKI, D.K., HART, S., MILLER, R.A. and LEVY, R., Induction of immune responses in patient with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors. N. Engl. J. Med., 327, 1209-1215 (1992).
11. KWAK, L.W., TAUB, D.D., DUFFEY, P.L., BENSINGER, W.I., BRYANT, E.M., REYNOLDS, C.W. and LONGO, D.L., Transfer of myeloma idiotypic-specific immunity from an actively immunised marrow donor. Lancet, 345, 1016-1020 (1995).
12. LARSEN, C.P., RITCHIE, S.C., HENDRIX, R., LINSLEY, P.S., HATHCOCK, K.S., HODES, R.J., LOWRY, R.P. and PEARSON, T.C., Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells. J. Immunol., 152, 5208-5219 (1994).
13. NESTLE, F.O., ALIJAGIC, S., GILLIET, M., SUN, Y., GRABBE, S., DUMMER, R., BURG, G. and SCHADENDORF, D., Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nature (Med.), 4, 328-332 (1998).
14. OSTERBORG, A., YI, Q., BERGENBRANT, S., HOLM, G., LEFVERT, A. and MELLSTEDT, H., Idiotypic-specific T cells in multiple myeloma stage I: an evaluation by four different functional tests. Brit. J. Haematol., 89, 110-116 (1995).
15. OSTERBORG, A., YI, Q., HENRIKSSON, L., FAGERBERG, J., BERGENBRANT, S., JEDDI-TEHRANI, M., RUDEN, U., LEFVERTY, A., HOLM, G. and MELLSTEDT, H., Idiotype immunization combined with granulocyte-macrophage colony stimulating factor in myeloma patients induced type 1, major histocompatibility complex-restricted, CD8- and CD4-specific T-cell responses. Blood, 91, 2459-2466 (1998).
16. ROMANI, N., GRUNER, S., BRANG, D., KAMPGEN, E., LENZ, A., TROCKENBACHER, B., KONWALINKA, G., FRITSCH, P.O., STEINMAN, R.M. and SCHULER, G., Proliferating dendritic cell progenitors in human blood. J. exp. Med., 180, 83-93 (1994).
17. ROSENBERG, S.A. AND 15 OTHERS, Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nature (Med.), 4, 321-327 (1998).
18. SALLUSTO, F. and LANZAVECCHIA, A., Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J. exp. Med., 179, 1109-1118 (1994).
19. WEN, Y.J. and LIM, S.H., T cells recognize the VH complementarity-determining region 3 of the idiotypic protein of B cell non-Hodgkin's lymphoma. Europ. J. Immunol., 27, 1043-1047 (1997).
20. WEN, Y.J., LING, M., BAILEY-WOOD, R. and LIM, S.H., Idiotypic protein-pulsed adherent peripheral blood mononuclear cell-derived dendritic cells prime immune system in multiple myeloma. Clin. Cancer Res., 4, 957-962 (1998a).
21. WEN, Y.J., LING, M. and LIM, S.H., Immunogenicity and cross-reactivity with idiotypic 1gA of VH CDR3 peptide in multiple myeloma. Brit. J. Haematol., 100, 464-468 (1998b).